(
EMAILWIRE.COM, January 29, 2018 ) The
North America HIV diagnostics Market was worth USD 652.14 million in 2016 and estimated to be growing at a CAGR of 9.0%, to reach 1003.4 million by 2021. The human immunodeficiency virus (HIV) refers to a kind of retrovirus that causes (AIDS). HIV affects some immune cells and it weakens immune system bringing about loss of capacity to fight against the organisms that causes diseases.
HIV spreads through exchange of fluids with some infected individual, for example, blood exchange or imparting needles to somebody who is HIV infected. Additionally, HIV can spread from infected mother to child during pregnancy. Here are some of the symptoms of HIV disease are weakness, slight fever, swollen glands, cerebral pains and muscle hurts. The present situation is like various POC/rapid tests are under clinical advancement and examination in the item pipelines of significant market members and are relied upon to acquire regulatory approval in various local segments of the market. This normal increment in the quantity of item offerings to the worldwide market space is required to fuel the development of the HIV diagnostics industry over the forecast period.
Browse market data tables and in-depth TOC of the North America HIV diagnostics Industry to 2021 @
http://www.marketdataforecast.com/market-reports/north-america-hiv-diagnostics-market-2146/Major factors driving the market are, the technological advancement of disease diagnostic tests, and the foreseen improvement and commercialization of novel, regulatory authorities approved POC and rapid CD4, p24 antigen and EID tests; it is expected that all the major regional market segments will witness an expansion in market demand over the forecast period. There is a need to increase in introducing easily accessible, efficient robust diagnostics tests. Because of the financial resource constrained settings in a huge share of the disease affected regions it is as yet not feasible to perform the current, complex screening, staging and monitoring tests. This is either because of the absence of adequate testing labs or an absence of prepared clinical technicians capable of performing the tests. These limitations of laboratory based testing are a catalyst to the improvement of convenient and simple to execute point of care, rapid tests.
The North America HIV Diagnostics Market is categorized on the basis of Product, End-User, Type, and geography. Based on product, market is divided into Instruments, Consumables (Assays and Kits & Reagents, Other consumables), Software & Services. Based on Type, market is segmented into HIV-2 & Group O Diagnostic Tests, Antibody Tests, Viral Identification Tests, Viral load testing, CD4 Testing, Early Infant Diagnostics. Further, on the basis of Antibody tests, the market is segmented into (HIV-1 Screening tests- Elisa/EIA, Home Access Dried blood spots. Rapid Tests), (HIV-1 Antibody Confirmatory Tests- Western Blot Test, Line immunoassays(Cnf), Indirect immunofluorescence Assays(IFA), Radio immunoprecipitation Assays(RIPA)). Based on HIV-2 & Group O Diagnostic Tests, the market is further categorized into Blood Antibody Tests, Line Immuno Assay (HIV-2), DBS Tests, and based on Viral Identification Tests, market is divided into Qualitative PCR Tests, p24 Antigen Test, Viral Culture. On the basis of geography, the North America market is analyzed under various regions namely U.S and Canada. HIV Diagnostics Market was dominated by North America, with the overall market share of over 38% globally. North America was followed by Asia pacific.
Free sample of the report is available @
http://www.marketdataforecast.com/market-reports/north-america-hiv-diagnostics-market-2146/request-sampleSome of the major companies leading the market, by their products as well as services include Abbott Healthcare, Alere Inc., Abbvie Inc., Brsitol-Myers Squibb, Gilead Sciences, Merck & Co. Inc, Janssen Therapeutics, BD Biosciences, VIIV Healthcare, Partec, Sysmex, Beckman Coulter, Apogee Flow Systems, Mylan inc., PointCare Technologies Inc., Zyomyx Inc., Roche Diagnostics, Siemens Healthcare, Qiagen, and bioMerieux
Market Segmentation
1) Product
Introduction
Consumables
Assays and Kits &Reagents
Other Consumables
Instruments
Software & Services
Y-o-Y Growth Analysis, By Product
Market Attractiveness Analysis, By Product
Market Share Analysis, By Product
2) Type
Introduction
Antibody Tests
HIV Screening Tests
Elisa
Rapid Tests
Home Access Dried Blood Spots
HIV-1 Antibody Confirmatory Tests
Western Blot Tests
Indirect Immunofluorescence Assays (IFA)
Line Immunoassays
Radio-Immunoprecipitation Assays
HIV-2 & Group O Diagnostic Tests
Blood Antibody Tests
DBS Tests
Line ImmunoAssay (HIV2)
Viral Identification Tests
P24 Antigen Test
Qualitative PCR Tests
Viral Culture
CD4 Testing
Viral Load testing
Early Infant Diagnostics
Y-o-Y Growth Analysis, By Type
Market Attractiveness Analysis, By Type
Market Share Analysis, By Type
3) End User
Introduction
Diagnostic Laboratories
Hospitals
Blood Banks
Home Care Settings
Other End Users
Y-o-Y Growth Analysis, By End User
Market Attractiveness Analysis, By End User
Market Share Analysis, By End User
Inquire before Buying at
http://www.marketdataforecast.com/market-reports/north-america-hiv-diagnostics-market-2146/inquireReasons to buy North America HIV Diagnostics Market Research Report:
Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
Segment-level analysis in terms of Product, Type and End User along with market size forecasts and estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of the effect of exogenous and endogenous factors that affect the North America market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analyzing the level of competition and business strategy development
A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.comSource:
EmailWire.Com 
